Cystic acne is a dangerous skin condition. It is the most serious type of acne wherein the pores of the skin get blocked. This blockage leads to infection or inflammation of the affected area of the skin. A new report on the global cystic acne market, published by Market Research Future (MRFR), scans this market to see a raise at 10% CAGR between 2017 and 2023.
The most significant market driving factor for the global cystic acne market growth is the rising prevalence of cystic acne conditions both in developed and developing countries. The major market players in the skincare industry and different research laboratories are involved in research development (RD) to develop formulas for medicines or ointments provide better treatment. Other factors contributing to the market growth include awareness about skin infections, demand for better skincare remedy, and trend among youngsters to be more conscious about their looks, increasing purchasing power of consumers, and subsequently increasing sales of anti-acne ointments.
Market Segmentation
The global cystic acne market segmentation encompasses end-user, causes, long-term effects, and treatment type. MRFR’s take on the market surveys various facets of the market in-depth.
Regarding end-user, this market has been segmented into clinics, hospitals, research laboratories, and others. The causes-based segmentation of this market covers drugs/chemical side effects, hormonal imbalances, occlusive skin products, and others.
As per the long-term effects, the market has been segmented into hypertrophic scarring, ice pick scars, larger pits on the skin, shallow depressions, and others. By treatment type, the market has been segmented into drainage extraction procedure, laser therapy, microdermabrasion, topical medications, and others.
Regional Segmentation
A geographical outlining of the global cystic acne market covers the Americas (North America South America), Asia Pacific, Europe, and the Middle East Africa (MEA).
The Americas region is dominating the global market as North America alone is strong enough to generate maximum market revenue. Due to technological advancements and availability of advanced medical facilities, North America is a bigger regional market segment, compared to South America. North America is a strong regional market segment due to the availability of well-developed technology, the growing use of technology in medical sector, presence of key market players, and increasing population with acne. American brands export their products to other regions too. In North America, maximum revenue comes from USA and Canada. In South America, the most vibrant economies are Argentina and Brazil that can be important markets in the future.
Europe is the second-largest market due to the availability of funds for research and government support for RD. Due to the reasons that are same as in the Americas, Western Europe is a bigger regional market than Eastern Europe. The most powerful country-specific markets in Europe are France, Germany, Italy, Spain, and the UK. An inspection of the remaining countries in Western Europe featured in this report speculate the huge contribution to market revenue from many other countries in this region with a sizable revenue from Eastern Europe too.
The Asia Pacific region is the fastest-growing regional market due to the high healthcare expenditure and presence of rapidly growing patient population. The governments of many Asian countries are focusing on providing better medical treatment to the citizen of their countries for improving their quality of life. Many market players in USA are trying capture the maximum share in the emerging markets like China and India. Other important country-specific markets in this region are Australia, Japan, and South Korea. An evaluation of the remaining countries in the Asia Pacific region featured in this report calculates the huge market revenue supply from some other countries.
In the MEA region, the market is small due to the ignorance of diseases, limited screening, and poor access to treatment. Some of the key country-specific markets in this region are Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. A valuation of the remaining countries in the MEA region featured in this report anticipates a decent contribution to market revenue from some other countries.
Key Players
Big players in the global cystic acne market include Abbott Laboratories (USA), Alma Lasers Inc. (Israel), Bristol-Myers Squibb Company (USA), DUSA Pharmaceuticals Inc. (USA), GE Healthcare (UK), Herbert Waldmann GmbH Co. KG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline PLC (UK), Hexal AG (Germany), National Biological Corp. (USA), Pfizer Inc. (USA), and Sylvan Company (USA).
Latest Industry News
• A new skin-care brand Knours is working on manufacturing and launching products that can cure hormonal acne. Considering the acnes that can be caused by hormonal imbalances, the products of Knours have been designed to work the menstrual cycle of the users and combat hormonal breakouts and to make the complexion of user beautiful. 11 JUNE 2019

https://www.marketresearchfuture.com/reports/cystic-acne-market-1723